- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
US Oncology Research Achieves Milestone of Over 100 FDA-Approved Cancer Therapies
Available in patients’ own communities, novel clinical trials are making an impact in the fight against cancer.
THE WOODLANDS, Texas — US Oncology Research, one of the largest community-based oncology research site management organizations in the United States, is celebrating the significant milestone of contributing to the FDA approval of more than 100 cancer therapies. This achievement is a result of the hard work and dedication to research from more than 165 research locations conducting more than 1600 clinical trials for cancer therapy. More than 80,000 participants have enrolled in clinical trials since 1999.
“US Oncology Research’s core mission is to bring potentially life-saving and life-improving treatments to the community where patients seek care,” said Robert L. Coleman, MD, FACOG, FACS, chief scientific officer, US Oncology Research. “These new interventions come from expert stewardship and execution of clinical research protocols positioned to better understand cancer biology and challenge the status quo. We are, therefore, incredibly proud of this milestone, which reflects the dedication and collective spirit of investigators across The US Oncology Network, committed to defining the next treatment standard. Research is a team sport dedicated to the individual patient.”
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
